029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
FOV811卵巢癌及正常组织组合芯片（WHO+1999版），附病理分级、TNM和临床分期，40例/80点
点 数80例 数40
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:FOV811
 
卵巢癌及正常组织组合微阵列，包含粘液性腺癌16例，浆液性腺癌15例，透明细胞癌和移行细胞癌各1例，子宫内膜样癌2例，卵巢组织5例，一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ova
-Ovary
 
Malignant (*)
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIC)
 
Malignant (IV)
 
Normal (*)
TISSUE  ARRAYS FOV811
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1162FOvaryMucinous papillary adenocarcinoma1T1N0M0IMalignantN
A2262FOvaryMucinous papillary cystadenocarcinoma1T1N0M0IMalignantN
A3352FOvaryMucinous papillary cystadenocarcinoma1T1N0M0IMalignantN
A4452FOvaryMucinous papillary cystadenocarcinoma (mucous tissue)*T1N0M0IMalignantN
A5548FOvaryMucinous papillary cystadenocarcinoma1T3aN1M1IVMalignantN
A6648FOvaryMucinous papillary cystadenocarcinoma1T3aN1M1IVMalignantN
A7743FOvaryMucinous papillary cystadenocarcinoma1T3cN0M0IIICMalignantN
A8843FOvaryMucinous papillary cystadenocarcinoma1T3cN0M0IIICMalignantN
A9951FOvaryMucinous papillary cystadenocarcinoma1**MalignantN
A101051FOvaryMucinous papillary cystadenocarcinoma1**MalignantN
B11138FOvaryMucinous papillary cystadenocarcinoma1T2bN0M0IIBMalignantN
B21238FOvaryMucinous papillary cystadenocarcinoma1T2bN0M0IIBMalignantN
B31323FOvaryMucinous papillary cystadenocarcinoma1T1cN0M0ICMalignantN
B41423FOvaryMucinous papillary cystadenocarcinoma1T1cN0M0ICMalignantN
B51537FOvaryMucinous papillary adenocarcinoma1-2T1aN0M0IAMalignantN
B61637FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignantN
B71740FOvaryMucinous papillary adenocarcinoma2T2N0M0IIMalignantN
B81840FOvaryMucinous papillary cystadenocarcinoma1T2N0M0IIMalignantN
B91951FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignantN
B102051FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignantN
C12164FOvaryMucinous cystadenocarcinoma1T1aN0M0IAMalignantN
C22264FOvaryMucinous cystadenocarcinoma1T1aN0M0IAMalignantN
C32329FOvaryMucinous papillary adenocarcinoma2T1cN0M0ICMalignantN
C42429FOvaryMucinous papillary adenocarcinoma2T1cN0M0ICMalignantN
C52534FOvaryMucinous papillary adenocarcinoma2T2cN1M0IIICMalignantN
C62634FOvaryMucinous papillary adenocarcinoma2T2cN1M0IIICMalignantN
C72747FOvaryMucinous papillary adenocarcinoma1-2T1N0M0IMalignantN
C82847FOvaryMucinous papillary adenocarcinoma1-2T1N0M0IMalignantN
C92950FOvaryMucinous adenocarcinoma2T3cN1M0IIICMalignantN
C103050FOvaryMucinous adenocarcinoma2T3cN1M0IIICMalignantN
D13151FOvaryMucinous adenocarcinoma3T1N0M0IMalignantN
D23251FOvaryMucinous adenocarcinoma3T1N0M0IMalignantN
D33356FOvarySerous papillary adenocarcinoma1T1cN0M0ICMalignantN
D43456FOvarySerous papillary adenocarcinoma1T1cN0M0ICMalignantN
D53546FOvarySerous papillary adenocarcinoma1T3N0M0IIIAMalignantN
D63646FOvarySerous papillary adenocarcinoma1T3N0M0IIIAMalignantN
D73740FOvarySerous papillary adenocarcinoma1-2T1N0M0IMalignantN
D83840FOvarySerous papillary adenocarcinoma1-2T1N0M0IMalignantN
D93930FOvarySerous papillary adenocarcinoma1T1N0M0IMalignantN
D104030FOvarySerous papillary adenocarcinoma1T1N0M0IMalignantN
E14152FOvarySerous papillary adenocarcinoma2T3aN0M0IIIAMalignantN
E24252FOvarySerous papillary adenocarcinoma2T3aN0M0IIIAMalignantN
E34370FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
E44470FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
E54563FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
E64663FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
E74759FOvarySerous papillary adenocarcinoma2T3aN0M0IIIAMalignantN
E84859FOvarySerous papillary adenocarcinoma2T3aN0M0IIIAMalignantN
E94950FOvarySerous papillary adenocarcinoma2T3aN1M0IIICMalignantN
E105050FOvarySerous papillary adenocarcinoma2T3aN1M0IIICMalignantN
F15147FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignantN
F25247FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignantN
F35361FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignantN
F45461FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignantN
F55560FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
F65660FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
F75752FOvarySerous adenocarcinoma3T1N0M0IMalignantN
F85852FOvarySerous adenocarcinoma3T1N0M0IMalignantN
F95943FOvarySerous adenocarcinoma***MalignantN
F106043FOvarySerous adenocarcinoma (sparse)3**MalignantN
G16156FOvarySerous adenocarcinoma3T2N1M0IIICMalignantN
G26256FOvarySerous adenocarcinoma3T2N1M0IIICMalignantN
G36368FOvaryClear cell carcinoma*T1N0M0IMalignantN
G46468FOvaryClear cell carcinoma*T1N0M0IMalignantN
G56570FOvaryTransitional cell carcinoma*T1N0M0IMalignantN
G66670FOvaryTransitional cell carcinoma*T1N0M0IMalignantN
G76745FOvaryEndometrioid carcinoma*T2N0M0IIMalignantN
G86845FOvaryEndometrioid carcinoma*T2N0M0IIMalignantN
G96940FOvaryEndometrioid carcinoma*T2N1M0IIICMalignantN
G107040FOvaryEndometrioid carcinoma*T2N1M0IIICMalignantN
H17121FOvaryOvary tissue***NormalN
H27221FOvaryOvary tissue***NormalN
H37321FOvaryOvary tissue***NormalN
H47421FOvaryOvary tissue***NormalN
H57518FOvaryOvary tissue***NormalN
H67618FOvaryOvary tissue***NormalN
H77721FOvaryOvary tissue***NormalN
H87821FOvaryOvary tissue***NormalN
H97921FOvaryOvary tissue***NormalN
H108021FOvaryOvary tissue***NormalN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情